LEXICON PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Earnings Per Share, Basic and Diluted of -$0.22 per share for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-03-12
- LEXICON PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-06-30 was -$0.22.
- LEXICON PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-03-31 was -$0.21.
- LEXICON PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2018-12-31 was -$0.16.
- LEXICON PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2018-09-30 was -$0.26.
- LEXICON PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.14.
- LEXICON PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.17.
- LEXICON PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2016 was -$1.27.
- LEXICON PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2015 was -$0.05.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$0.22 10-Q · filed 2019-08-01 | -$0.42 10-Q · filed 2019-08-01 | ||||||
| 2019-03-31 | -$0.21 10-Q · filed 2019-05-01 | |||||||
| 2018-12-31 | -$0.16 10-K · filed 2020-03-12 | -$1.14 10-K · filed 2019-03-15 | ||||||
| 2018-09-30 | -$0.26 10-K · filed 2020-03-12 | -$0.99 10-Q · filed 2018-11-01 | ||||||
| 2018-06-30 | -$0.33 10-K · filed 2020-03-12 | -$0.72 10-Q · filed 2019-08-01 | -$0.73 10-Q · filed 2018-07-30 | |||||
| 2018-03-31 | -$0.40 10-K · filed 2020-03-12 | |||||||
| 2017-12-31 | -$0.25 10-K · filed 2019-03-15 | -$0.27 10-K · filed 2018-03-01 | -$1.17 10-K · filed 2019-03-15 | -$1.23 10-K · filed 2018-03-01 | ||||
| 2017-09-30 | -$0.28 10-K · filed 2019-03-15 | -$0.29 10-Q · filed 2017-11-08 | -$0.96 10-Q · filed 2018-11-01 | |||||
| 2017-06-30 | -$0.33 10-K · filed 2019-03-15 | -$0.67 10-Q · filed 2018-07-30 | ||||||
| 2017-03-31 | -$0.31 10-K · filed 2019-03-15 | -$0.33 10-Q · filed 2017-05-04 | ||||||
| 2016-12-31 | -$0.31 10-K · filed 2018-03-01 | -$0.66 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.03 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.27 10-K · filed 2019-03-15 | -$1.36 10-K · filed 2017-03-06 | |||
| 2016-09-30 | -$0.35 10-K · filed 2018-03-01 | -$0.71 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.05 10-Q · filed 2017-11-08 | -$0.21 derived: net income ÷ weighted average shares · filed 2018-03-01 | ||||
| 2016-06-30 | -$0.37 10-K · filed 2018-03-01 | -$0.70 10-Q · filed 2017-08-01 | $0.13 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.21 derived: net income ÷ weighted average shares · filed 2018-03-01 | ||||
| 2016-03-31 | -$0.34 10-K · filed 2018-03-01 | $0.50 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.16 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.09 derived: net income ÷ weighted average shares · filed 2018-03-01 | ||||
| 2015-12-31 | $0.84 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.50 derived: net income ÷ weighted average shares · filed 2018-03-01 | $0.25 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.05 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | -$0.34 10-Q · filed 2016-11-07 | -$0.59 derived: net income ÷ weighted average shares · filed 2017-03-06 | -$0.88 10-Q · filed 2016-11-07 | -$0.93 derived: net income ÷ weighted average shares · filed 2017-03-06 | ||||
| 2015-06-30 | -$0.27 10-Q · filed 2016-08-04 | -$0.54 10-Q · filed 2016-08-04 | -$0.59 derived: net income ÷ weighted average shares · filed 2017-03-06 | -$1.07 derived: net income ÷ weighted average shares · filed 2017-03-06 | ||||
| 2015-03-31 | -$0.27 10-Q · filed 2016-05-05 | -$0.04 10-Q · filed 2015-05-05 | -$0.33 derived: net income ÷ weighted average shares · filed 2017-03-06 | -$0.82 derived: net income ÷ weighted average shares · filed 2017-03-06 | -$1.16 derived: net income ÷ weighted average shares · filed 2017-03-06 | |||
| 2014-12-31 | -$0.03 10-K · filed 2016-03-11 | $0.00 10-K · filed 2015-03-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2016-03-11 | -$0.90 derived: net income ÷ weighted average shares · filed 2016-03-11 | -$1.31 10-K · filed 2017-03-06 | -$0.19 10-K · filed 2015-03-12 | ||
| 2014-09-30 | -$0.55 10-K · filed 2016-03-11 | -$0.08 10-Q · filed 2014-11-06 | -$0.90 derived: net income ÷ weighted average shares · filed 2016-03-11 | -$1.32 10-Q · filed 2015-11-09 | -$0.19 10-Q · filed 2014-11-06 | |||
| 2014-06-30 | -$0.35 10-K · filed 2016-03-11 | -$0.05 10-Q · filed 2014-08-07 | -$0.77 10-Q · filed 2015-08-07 | -$0.11 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | -$0.42 10-K · filed 2016-03-11 | -$0.06 10-Q · filed 2014-05-08 | ||||||
| 2013-12-31 | -$0.03 10-K · filed 2015-03-12 | -$1.42 10-K · filed 2016-03-11 | -$0.20 10-K · filed 2014-03-07 | |||||
| 2013-09-30 | -$0.06 10-K · filed 2015-03-12 | -$0.17 10-Q · filed 2014-11-06 | ||||||
| 2013-06-30 | -$0.06 10-K · filed 2015-03-12 | -$0.11 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | -$0.05 10-K · filed 2015-03-12 | |||||||
| 2012-12-31 | -$0.05 10-K · filed 2014-03-07 | -$0.23 10-K · filed 2015-03-12 | ||||||
| 2012-09-30 | -$0.06 10-K · filed 2014-03-07 | -$0.18 10-Q · filed 2013-11-12 | ||||||
| 2012-06-30 | -$0.05 10-K · filed 2014-03-07 | -$0.12 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | -$0.06 10-K · filed 2014-03-07 | |||||||
| 2011-12-31 | -$0.10 10-K · filed 2013-03-11 | -$0.34 10-K · filed 2014-03-07 | ||||||
| 2011-09-30 | -$0.08 10-K · filed 2013-03-11 | -$0.24 10-Q · filed 2012-11-07 | ||||||
| 2011-06-30 | -$0.08 10-K · filed 2013-03-11 | -$0.17 10-Q · filed 2012-08-02 | ||||||
| 2011-03-31 | -$0.09 10-K · filed 2013-03-11 | |||||||
| 2010-12-31 | -$0.34 10-K · filed 2013-03-11 | |||||||
| 2010-09-30 | -$0.08 10-Q · filed 2011-11-01 | -$0.27 10-Q · filed 2011-11-01 | ||||||
| 2010-06-30 | -$0.07 10-Q · filed 2011-08-09 | -$0.19 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | -$0.57 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |